Your browser doesn't support javascript.
loading
Epidermal growth factor receptor positive lung cancer: The nontrial scenario.
Noronha, V; Patil, V M; Joshi, A; Tandon, N; Sharma, V; Ramaswamy, A; More, S B; Gaud, S; Prabhash, K.
Affiliation
  • Noronha V; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Patil VM; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Joshi A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Tandon N; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Sharma V; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Ramaswamy A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • More SB; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Gaud S; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Prabhash K; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Indian J Cancer ; 54(1): 132-135, 2017.
Article in En | MEDLINE | ID: mdl-29199676

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Disease-Free Survival / Protein Kinase Inhibitors / ErbB Receptors / Lung Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Indian J Cancer Year: 2017 Document type: Article Affiliation country: India Country of publication: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Disease-Free Survival / Protein Kinase Inhibitors / ErbB Receptors / Lung Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Indian J Cancer Year: 2017 Document type: Article Affiliation country: India Country of publication: India